Culture-negative versus culture-positive in pyogenic spondylitis and analysis of risk factors for relapse

References

• Lazzeri E, Bozzao A, Cataldo MA, et al. Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults. Eur J Nucl Med Mol Imaging 2019; 46:2464–87.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JG, Yi J, et al. Changes in the medical burden of pyogenic and tuberculous spondylitis between 2007 and 2016: a nationwide cohort study. J Clin Neurosci 2020;78:347–52.
   PubMed Web of Science ®Google Scholar
• Kim C-J, Kim EJ, Song K-H, et al. Comparison of characteristics of culture-negative pyogenic spondylitis and tuberculous spondylitis: a retrospective study. BMC Infect Dis 2016;16:560.
   PubMed Web of Science ®Google Scholar
• Menon KV, Sorour TM. Epidemiologic and demographic attributes of primary spondylodiscitis in a Middle Eastern population sample. World Neurosurg 2016;95:31–9.
   PubMed Web of Science ®Google Scholar
• Kim YH, Park JW, Kim JS, et al. The outcome of infected total knee arthroplasty: culture-positive versus culture-negative. Arch Orthop Trauma Surg 2015;135:1459–67.
   PubMed Web of Science ®Google Scholar
• Nickerson EK, Sinha R. Vertebral osteomyelitis in adults: an update. Br Med Bull 2016;117:121–38.
   PubMed Web of Science ®Google Scholar
• Lee YD, Jeon YH, Kim YH, et al. Clinical characteristics and outcomes of patients with culture-negative pyogenic spondylitis according to empiric glycopeptide use. Infect Chemother 2019;51:274–83.
   PubMed Web of Science ®Google Scholar
• Dogan M, Simsek AT, Yilmaz I, et al. Evaluation of empirical antibiotic treatment in culture negative pyogenic vertebral osteomyelitis. Turk Neurosurg 2019;29:816–22.
   PubMed Web of Science ®Google Scholar
• Weissman S, Parker RD, Siddiqui W, et al. Vertebral osteomyelitis: retrospective review of 11 years of experience. Scand J Infect Dis 2014;46:193–9.
   PubMed Web of Science ®Google Scholar
• Hopkinson N, Patel K. Clinical features of septic discitis in the UK: a retrospective case ascertainment study and review of management recommendations. Rheumatol Int 2016;36:1319–26.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim YS, Peck KR, et al. Outcome of culture-negative pyogenic vertebral osteomyelitis: comparison with microbiologically confirmed pyogenic vertebral osteomyelitis. Semin Arthritis Rheum 2014;44:246–52.
   PubMed Web of Science ®Google Scholar
• Park KH, Cho OH, Lee JH, et al. Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis 2016;62:1262–9.
   PubMed Web of Science ®Google Scholar
• Jean M, Irisson J, Gras G, et al. Diagnostic delay of pyogenic vertebral osteomyelitis and its associated factors. Scand J Rheumatol 2017;46:64–8.
   PubMed Web of Science ®Google Scholar
• Sato K, Yamada K, Yokosuka K, et al. Pyogenic spondylitis: clinical features, diagnosis and treatment. Kurume Med J 2019;65:83–9.
   PubMedGoogle Scholar
• Iwata E, Scarborough M, Bowden G, et al. The role of histology in the diagnosis of spondylodiscitis: correlation with clinical and microbiological findings. J Bone Joint Surg-Br 2019;101-B:246–52.
   Google Scholar
• Foreman SC, Schwaiger BJ, Gempt J, et al. MR and CT imaging to optimize CT-guided biopsies in suspected spondylodiscitis. World Neurosurg 2017;99:726–734.e7.
   PubMed Web of Science ®Google Scholar
• Kim C, Song K, Park WB, et al. Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure. Antimicrob Agents Chemother 2012;56:2122–4.
   PubMed Web of Science ®Google Scholar
• Li T, Liu T, Jiang Z, et al. Diagnosing pyogenic, brucella and tuberculous spondylitis using histopathology and MRI: a retrospective study. Exp Ther Med 2016;12:2069–77.
   PubMed Web of Science ®Google Scholar
• Bernard L, Dinh A, Ghout I, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 2015;385:875–82.
   PubMed Web of Science ®Google Scholar
• Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 2015;61:e26–e46.
   PubMed Web of Science ®Google Scholar
• Kim DY, Kim UJ, Yu Y, et al. Microbial etiology of pyogenic vertebral osteomyelitis according to patient characteristics. Open Forum Infect Dis 2020;7:ofaa176.
   PubMed Web of Science ®Google Scholar
• Ceroni D, Dayer R, Steiger C. Are we approaching the end of pediatric culture-negative osteoarticular infections? Future Microbiol 2019;14:917–9.
   PubMed Web of Science ®Google Scholar
• Pola E, Taccari F, Autore G, et al. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. Eur Spine J 2018;27:229–36.
   PubMed Web of Science ®Google Scholar
• Pola E, Autore G, Formica VM, et al. New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years. Eur Spine J 2017;26:479–88.
   PubMed Web of Science ®Google Scholar
• Kamal AM, El-Sharkawi MM, El-Sabrout M, et al. Spondylodiscitis: experience of surgical management of complicated cases after failed antibiotic treatment. SICOT J 2020;6:5.
   PubMed Web of Science ®Google Scholar
• Pola E, Pambianco V, Autore G, et al. Minimally invasive surgery for the treatment of thoraco lumbar pyogenic spondylodiscitis: indications and outcomes. Eur Rev Med Pharmacol Sci 2019;23:94–100.
   PubMed Web of Science ®Google Scholar